Upcoming Anticipated Clinical Milestones AMPLIFY-201: Provide updated RFS and OS data in an oral presentation at the 2024 ESMO Immuno-Oncology Congress, taking place from December 11-13, 2024, in ...

EMA granted clearance to advancebelrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in ...

In July, Immutep reported updated positive efficacy and safety results from Cohort B of the TACTI-003 Phase IIb trial at an ESMO Virtual Plenary session ... chemotherapy in patients with CPS <1. The ...

at the European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress 2024 taking place 11-13 December in Geneva, Switzerland. Abstracts will be made available on the ESMO I-O website ...

Welcome to Medscape's ESMO 2017 Live Blog. Throughout the ESMO 2017 Congress in Madrid, experts from across a range of cancer tumor types will provide real-time coverage of the most important ...

A rumor that food company Land O'Lakes had announced a return to its previous logo featuring a kneeling Indigenous woman on its packaging circulated online in October 2024. A Facebook post ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

Explore the YouTube logo design, uncover psychology, and learn tips for creating unforgettable logos. Elevate your brand with expert insights. Have you ever caught yourself mindlessly scrolling ...

Oncology has undergone a number of treatment advances in the last decade, the most recent of which – the advent of successful immuno-oncology options – is poised to upend how we position ...

The most notable immuno-oncology antibody in development is BNT 327, a bispecific molecule that targets PD-L1 and VEGF. In-licensed from Biotheus in October 2023, this asset has generated ...